Clinical Trial Update: Continuous Glucose Monitoring Using a New Subcutaneous Insulin Protocol for Mild to Moderate Diabetic Ketoacidosis [NA]

View source ↗

Summary

A clinical trial evaluating continuous glucose monitoring with a new subcutaneous insulin protocol for mild to moderate diabetic ketoacidosis has been withdrawn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Ketoacidosis
• Hyperglycemia

Drugs mentioned

• Insulin (insulin)

Snippet

Sponsor: HealthPartners Institute | Conditions: Diabetic Ketoacidosis, Hyperglycemia | NA | Status: WITHDRAWN